Transcript Document
Clinical Programmes Gloucestershire Commissioning for outcomes Justine Rawlings Associate Director Clinical Programmes Introduction - Clinical programmes: - Based on 23 programme budgeting categories - Benchmarked spend and outcomes for these areas - Identify priority programme areas for which we are an outlier - Priority programmes for our focus in next 2 years MSK outcomes • The national SPOT tool suggested the following benchmarked outcomes: • MSK: Initially higher spend average outcome. Now higher spend is decreasing and outcome still average. Note: spend/head has stayed roughly the same as cluster average • Trauma: initially higher spend and lower outcome. Spend has decreased over the years, but outcomes still below average • • (Outcomes used by SPOT tool MSK: hip replacement and knee replacement; EQ-5D Health gain 2010/11; Oxford hip score health gain 2010/11 (HES online); Trauma: Mortality from accidents DSR; Mortality from accidental falls DSR, Mortality from fractured NOF, Mortality from skull fracture and intercranial injury, Mortality from land transport accidents) 2015/16: Focus to reduce to quartile benchmarked position CPG Category High level description MSK & Trauma Outpatient general 1st attendances Outpatient Outpatient - New/1st - follow-up Elective Emergency Cost of variance (£000k) Cost of variance (£000k) Cost of variance (£000k) Cost of variance (£000k) v quartile v quartile v quartile v quartile 800 Outpatient general F/up attendances 1,200 Hips 1,300 Elbows and lower arms 200 Feet trauma 230 Reconstruction (mainly revisions of hip, knees, shoulder) 1,060 Spinal (mainly extradural) TOTAL by Worktype 250 690 800 1200 3050 TOTAL Notes: T&O new OP: 1sts only small % over average T&O f-up OP: Follow up ratio 2.1 v 1.8 Reconstruction – this in large part relates to reconstruction following initial joint replacement surgery and so cannot be delivered as a saving until the initial surgery rate is reduced. NB Reconstruction will be 10-15 years after the initial surgery 680 5,730 Service context • Some evidence of demand management in areas where there was a physiotherapy interface service • Some evidence that patients being referred that do not require surgery • Variation in provision/use of of interface and core physiotherapy service and conservative management options e.g. weight loss programmes CPG set up • Clinical and managerial representation commissioners and providers • JD for consultant and GP lead including commitment to take back and consult within organisation and provide overall view • Layworker rep and healthwatch rep • Commitment to doing what makes clinical sense for the patient Developing criteria and guidelines • Detailed guidelines developed for all major joints • Included advice and best practice for GP, physio, interface and surgical IFR criteria • BUT • Thresholds ambiguous if you wanted to use it to manage flow/demand manage Strengthening thresholds • Clinical workshop review of guidelines and simplifying: • what needs to be done prior to surgical referral – E.g. conservative management and timescale – Weight loss – Patient wants surgery *(shared decision making) • Clear IFR policies for surgical intervention that will be auditable and audited Outcomes • National outcome measures not comprehensive • We need measures for whole pathway not single providers • Agreed principles and framework aligned to National Outcomes Framework • In first year increased range of PROMs and use EQ5DL Principles Suggested principles for agreed outcome measures are: • The number of measures should be kept to those that are meaningful, measurable and likely to be used • Measures are for the whole MSK population and are NOT the same as provider based performance measures i.e. one patient may have multiple interventions from multiple providers which influence the outcome • The measures should be applied to conditions that can demonstrate: – Amenability to intervention – Sensitivity to intervention • The scope of outcomes measured should include both measures that are patient reported and service level outcome measures (i.e. no patient input to measure required.) • Process measures can be used as proxies if useful where no suitable outcome measure exists (particularly in order to capture intermediate measures where outcomes are longer term) • Measures, including mode of delivery should be consistent across services and providers • Measures should be appropriate to an intervention and should include measures for interventions dealing with prevention, episodic care and interventions for chronic conditions. • Measures should take account of the whole pathway, ideally across all interventions including where a patient has declined or not been accepted for an intervention. (e.g. where shared decision-making has been part of the process) • Outcome group Service level outcome measures/quality and service standards contributing to outcomes Patient reported outcome measures Prevention Reduction in recurrent osteoporotic fractures Reduction in fracture risk Prescription of medications for osteoporosis Limitation of self-reported occurrence of MSK pain Waiting times for MSK patient between 1st GP attendance and 1st referral for specialist care Waiting time for rheumatoid arthritis patient between 1st symptomatic presentation at GP practice and treatment with disease modifying anti-rheumatoid drugs (DMARD) Acute single episodes Episodic conditions Emergency readmissions within 28 days of discharge Percentage of patients returning home Length of stay Reoperation rates Surgical complication rates National joint registry Surgical site infections Surgical revisions Theatre access time Timeliness of care Percentage of patients returning to work within n days of episode beginning (where research is required to define “n”) Number of days off work amongst people with MSK disorders in contact with health services over a given time period Percentage of patients self-reporting changes in pain and mobility after episode Percentage of patients self-reporting a return to function Using EQ5DL, national PROMs (hips and knees) and potentially PROMS for other MSK conditions (CQUIN – GHFT spine) Suggest : spines, foot/ankle and potentially shoulder in first instance) Shared decision making EQ5DL PROMS Percentage of patients self-reporting that they have returned to “normality” e.g.: self-reported return to work, absence of pain, or self-reported return to domicile Employment support allowance (ESA) claimed per head of MSK population during given time ASCOF data Long term conditions Percentage of patients returning to work within n days of episode beginning (where research is required to define “n”) Number of days off work amongst people with MSK disorders in contact with health services over a given time period Disease activity score (DAS) – rheumatoid arthritis Percentage of patients self-reporting that they have returned to “normality” e.g.: self-reported return to work, absence of pain, or self-reported return to domicile Further work One system one budget • Care pathways programme • Single approach to service development In year programmes to support • Advice and guidance • Peer review